Lipid-lowering agent

This page covers all Lipid-lowering agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HMG-CoA reductase.

Targets

HMG-CoA reductase

Marketed (1)

• No Lutinus + transfer day 7 · Anja Bisgaard Pinborg · Cardiovascular
  No Lutinus is a medication that works by inhibiting the action of certain enzymes in the body.

Phase 3 pipeline (2)

• OmegaD · OmegaD LLC · Cardiovascular
  OmegaD is a small molecule that modulates the activity of a specific enzyme involved in lipid metabolism.
• Lipid Modifying Therapy (LMT) · Sanofi · Cardiovascular
  Lipid Modifying Therapy reduces circulating lipid levels through modulation of lipid metabolism pathways to lower cardiovascular risk.